Variable | Value | GP consultationa | Â | GP prescriptionb | Â |
---|---|---|---|---|---|
Palliative care | Yes | 1.30(1.29 to 1.32) | < 0.0001 | 1.17(1.16 to 1.18) | < 0.0001 |
Age at death (ref: < 50) | 50–59 | 0.98(0.95 to 1.01) | < 0.0001 | 1.09(1.04 to 1.13) | < 0.0001 |
60–69 | 0.97(0.95 to 1.00) |  | 1.21(1.16 to 1.25) |  | |
70–79 | 0.95(0.93 to 0.98) |  | 1.26(1.22 to 1.31) |  | |
80–89 | 0.90(0.88 to 0.93) |  | 1.28(1.23 to 1.33) |  | |
90+ | 0.85(0.83 to 0.88) | Â | 1.34(1.29 to 1.40) | Â | |
Gender (ref: female) | Male | 0.96(0.95 to 0.97) | < 0.0001 | 0.93(0.91 to 0.94) | < 0.0001 |
Cancer site (ref: Lung) | Colorectal | 1.01(1.00 to 1.03) | < 0.0001 | 1.06(1.04 to 1.08) | < 0.0001 |
Breast | 1.04(1.03 to 1.05) | Â | 0.97(0.96 to 0.99) | Â | |
Prostate | 1.22(1.20 to 1.24) | Â | 1.15(1.13 to 1.17) | Â | |
No. comorbidity conditions (ref: 0) | 1 | 1.09(1.08 to 1.11) | < 0.0001 | 1.20(1.18 to 1.22) | < 0.0001 |
2 | 1.21(1.19 to 1.22) | Â | 1.43(1.40 to 1.45) | Â | |
3 | 1.30(1.28 to 1.32) | Â | 1.62(1.59 to 1.65) | Â | |
4+ | 1.42(1.39 to 1.44) | Â | 1.92(1.88 to 1.95) | Â | |
Time between diagnosis and death (months) (ref: 120+) | < 6 | 1.06(1.03 to 1.09) | < 0.0001 | 0.99(0.95 to 1.02) |  |
6–12 | 1.27(1.23 to 1.31) |  | 1.09(1.05 to 1.12) | < 0.0001 | |
13–36 | 1.09(1.06 to 1.11) |  | 1.06(1.03 to 1.10) |  | |
37–60 | 1.04(1.01 to 1.07) |  | 1.04(1.01 to 1.07) |  | |
61–120 | 1.00(0.97 to 1.03) |  | 1.00(0.97 to 1.03) |  | |
Year of death (ref: 2010–2014) | 2000–2004 | 0.63(0.61 to 0.65) | < 0.0001 | 0.82(0.81 to 0.84) | < 0.0001 |
2005–2009 | 0.87(0.85 to 0.88) |  | 0.93(0.91 to 0.94) |  | |
Region (ref: England) | Wales | 0.98(0.92 to 1.04) | < 0.0001 | 1.14(1.09 to 1.19) | < 0.0001 |
Scotland | 1.13(1.06 to 1.20) | Â | 0.98(0.94 to 1.02) | Â | |
NI | 1.57(1.43 to 1.71) | Â | 1.15(1.07 to 1.24) | Â |